Pharmacy Times September 26, 2024
Clayton Irvine, PharmD, MBA, MS, notes that although these options help to lower the cost of care, quick, widespread implementation remains difficult.
Pharmacy Times® interviewed Clayton Irvine, PharmD, MBA, MS, senior manager, oncology cancer care at Mayo Clinic, about the cost of cancer care. Irvine discussed how advancements in health care technology can contribute to the overall costs for cancer care, and that biosimilar or generic treatments can be helpful for lowering costs; however, it is difficult for health systems to quickly implement these products on such a large scale. He also emphasized the significance of transparency, notably around drug pricing and rebates, when it comes to pharmacy benefit manager (PBM) activity.
Irvine was one of several panelist speakers at...
Today's Sponsors
Today's Sponsor